Scroll to Top

USA Stock Report

Real Time Stocks News

Boston, MA, 04/09/2014 (usastockreports) –  Chief Justice John Roberts of U.S. Supreme Court have asked the generic-drug makers to answer to Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on the company’s bid. The drug makers have still not responded on the matter of patent fight over Copaxone. It is Teva’s top-selling multiple sclerosis drug. The court...

Boston, MA, 03/12/2014 – Oncogenex Pharmaceuticals Inc (NASDAQ:OGXI) is concerned with the development of new cancer products. Treatment for cancer has global market opportunity and the company has been hoping that its product pipeline will soon come of age to propel its revenue and earnings. However, investors are not pretty sure whether to hit the panic button...

Boston, MA, 02/20/2014 – Tesla Motors Inc (NASDAQ:TSLA) became the biggest gainer after hours as it beats EPS in its fourth quarter and gave away the guidance signalling growth story. The electric car maker delivered $615 million revenue in the said quarter, missing the estimate by approximately $42 million. But, it exceeded the EPS estimate by $0.12 by being at...

Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) has announced an agreement with Handok Pharmaceuticals Co., Ltd. (KRX:002390) to establish a joint venture in South Korea. For Teva, one of the world’s biggest generic drug makers, this is its first commercial deal in East Asia outside of Japan. The company claims that the South Korean pharmaceutical market is worth...

Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA), one of the world’s biggest generic drug makers, has updated its guidance for expected non-GAAP financial performance for the upcoming full year ending December 31, 2013. In a related conference call, it was announced that on December 11th Teva’s new CEO, Jeremy Levin, will detail plans to reshape the company –...